(1) | Adjusted net income per diluted share is a non-GAAP financial measure; please see definition of Adjusted Net Income Per Diluted Share in Footnote Table 3 and 4. | |
(2) | Adjusted operating margin is a non-GAAP financial measure; please see reconciliation of Operating Income to Adjusted Operating Income in Footnote Table 1 and 2. | |
(3) | Free cash flow is a non-GAAP financial measure; please see reconciliation of Cash Flows from Operating Activities to Free Cash Flow in Footnote Table 5. | |
(4) | Adjusted net income is a non-GAAP financial measure; please see reconciliation of Net Income to Adjusted Net Income in Footnote Table 3 and 4. | |
(5) | Adjusted operating income is a non-GAAP financial measure; please see reconciliation of Operating Income to Adjusted Operating Income in Footnote Table 1 and 2. |
Three Months Ended | |||
September 30, | June 30, | ||
2025 | 2024 | 2025 | |
Revenue: | |||
Completion and Production | $3,223 | $3,299 | $3,171 |
Drilling and Evaluation | 2,377 | 2,398 | 2,339 |
Total revenue | $5,600 | $5,697 | $5,510 |
Operating income: | |||
Completion and Production | $514 | $669 | $513 |
Drilling and Evaluation | 348 | 406 | 312 |
Corporate and other | (64) | (60) | (66) |
SAP S4 upgrade expense | (50) | (28) | (32) |
Impairment and other charges (a) | (392) | (116) | — |
Total operating income | 356 | 871 | 727 |
Interest expense, net | (88) | (85) | (92) |
Other, net (b) | (49) | (52) | (24) |
Income before income taxes | 219 | 734 | 611 |
Income tax provision (c) | (199) | (154) | (131) |
Net income | $20 | $580 | $480 |
Net income attributable to noncontrolling interest | (2) | (9) | (8) |
Net income attributable to Company | $18 | $571 | $472 |
Basic and diluted net income per share | $0.02 | $0.65 | $0.55 |
Basic weighted average common shares outstanding | 849 | 881 | 857 |
Diluted weighted average common shares outstanding | 850 | 881 | 857 |
(a) | See Footnote Table 1 for details of the impairments and other charges recorded during the three months ended September 30, 2025 and September 30, 2024. | |||||
(b) | During the three months ended September 30, 2025, Halliburton incurred a charge of $23 million due to the impairment of an investment in Argentina. | |||||
(c) | The income tax provision during the three months ended September 30, 2025, includes a $125 million tax expense associated with a valuation allowance recorded against our United States foreign tax credits, as well as the tax effect on impairments and other charges and the impairment of an investment in Argentina. The income tax provision during the three months ended September 30, 2024, includes a $41 million tax benefit associated with a partial release of a valuation allowance on deferred tax assets based on market conditions, as well as the tax effect on impairments and other charges. | |||||
See Footnote Table 1 for Reconciliation of Operating Income to Adjusted Operating Income. | ||||||
See Footnote Table 3 for Reconciliation of Net Income to Adjusted Net Income. |
Nine Months Ended | ||
September 30, | ||
2025 | 2024 | |
Revenue: | ||
Completion and Production | $9,514 | $10,073 |
Drilling and Evaluation | 7,013 | 7,261 |
Total revenue | $16,527 | $17,334 |
Operating income: | ||
Completion and Production | $1,558 | $2,080 |
Drilling and Evaluation | 1,012 | 1,207 |
Corporate and other | (196) | (190) |
SAP S4 upgrade expense | (112) | (91) |
Impairment and other charges (a) | (748) | (116) |
Total operating income | 1,514 | 2,890 |
Interest expense, net | (266) | (269) |
Other, net (b) | (112) | (180) |
Income before income taxes | 1,136 | 2,441 |
Income tax provision (c) | (433) | (539) |
Net income | $703 | $1,902 |
Net income attributable to noncontrolling interest | (9) | (16) |
Net income attributable to Company | $694 | $1,886 |
Basic and diluted net income per share | $0.81 | $2.13 |
Basic weighted average common shares outstanding | 857 | 885 |
Diluted weighted average common shares outstanding | 858 | 886 |
(a) | See Footnote Table 2 for details of the impairments and other charges recorded during the nine months ended September 30, 2025 and September 30, 2024. | |||||
(b) | During the nine months ended September 30, 2025, Halliburton incurred a charge of $23 million due to the impairment of an investment in Argentina. During the nine months ended September 30, 2024, Halliburton incurred a charge of $82 million in March 2024, primarily due to the impairment of an investment in Argentina and currency devaluation in Egypt. | |||||
(c) | The income tax provision during the nine months ended September 30, 2025, includes a $125 million tax expense associated with a valuation allowance recorded against our United States foreign tax credits, as well as the tax effect on impairments and other charges and the impairment of an investment in Argentina. The tax provision during the nine months ended September 30, 2024, includes a $41 million tax benefit associated with a partial release of a valuation allowance on deferred tax assets on market conditions, as well as the tax effects on impairments and other charges, the impairment of an investment in Argentina and Egypt currency impact. | |||||
See Footnote Table 2 for Reconciliation of Operating Income to Adjusted Operating Income. | ||||||
See Footnote Table 4 for Reconciliation of Net Income to Adjusted Net Income. |
September 30, | December 31, | |||
2025 | 2024 | |||
Assets | ||||
Current assets: | ||||
Cash and equivalents | $2,026 | $2,618 | ||
Receivables, net | 5,161 | 5,117 | ||
Inventories | 3,095 | 3,040 | ||
Other current assets | 1,356 | 1,607 | ||
Total current assets | 11,638 | 12,382 | ||
Property, plant, and equipment, net | 5,174 | 5,113 | ||
Goodwill | 2,938 | 2,838 | ||
Deferred income taxes | 2,260 | 2,339 | ||
Operating lease right-of-use assets | 972 | 1,022 | ||
Other assets | 2,182 | 1,893 | ||
Total assets | $25,164 | $25,587 | ||
Liabilities and Shareholders' Equity | ||||
Current liabilities: | ||||
Accounts payable | $3,182 | $3,189 | ||
Accrued employee compensation and benefits | 745 | 711 | ||
Current maturities of long-term debt | 382 | 381 | ||
Current portion of operating lease liabilities | 294 | 263 | ||
Other current liabilities | 1,351 | 1,506 | ||
Total current liabilities | 5,954 | 6,050 | ||
Long-term debt | 7,157 | 7,160 | ||
Operating lease liabilities | 734 | 798 | ||
Employee compensation and benefits | 421 | 414 | ||
Other liabilities | 652 | 617 | ||
Total liabilities | 14,918 | 15,039 | ||
Company shareholders’ equity | 10,203 | 10,506 | ||
Noncontrolling interest in consolidated subsidiaries | 43 | 42 | ||
Total shareholders’ equity | 10,246 | 10,548 | ||
Total liabilities and shareholders’ equity | $25,164 | $25,587 |
Nine Months Ended | Three Months Ended | ||
September 30, | September 30, | ||
2025 | 2024 | 2025 | |
Cash flows from operating activities: | |||
Net income | $703 | $1,902 | $20 |
Adjustments to reconcile net income to cash flows from operating activities: | |||
Depreciation, depletion, and amortization | 846 | 804 | 285 |
Impairments and other charges | 748 | 116 | 392 |
Working capital (a) | (111) | (645) | (211) |
Other operating activities | (425) | 232 | 2 |
Total cash flows provided by operating activities | 1,761 | 2,409 | 488 |
Cash flows from investing activities: | |||
Capital expenditures | (917) | (1,016) | (261) |
Purchase of an equity investment | (343) | (101) | 2 |
Payments to acquire business | (175) | (27) | (13) |
Purchases of marketable securities | (128) | (320) | (13) |
Sales of marketable securities | 228 | 137 | 163 |
Proceeds from sales of property, plant, and equipment | 138 | 149 | 49 |
Sale of an equity investment | 120 | — | — |
Other investing activities | (49) | (32) | (13) |
Total cash flows used in investing activities | (1,126) | (1,210) | (86) |
Cash flows from financing activities: | |||
Stock repurchase program | (757) | (696) | (250) |
Dividends to shareholders | (436) | (452) | (144) |
Other financing activities | (23) | (37) | (11) |
Total cash flows used in financing activities | (1,216) | (1,185) | (405) |
Effect of exchange rate changes on cash | (11) | (100) | (9) |
Decrease in cash and cash equivalents | (592) | (86) | (12) |
Cash and equivalents at beginning of period | 2,618 | 2,264 | 2,038 |
Cash and equivalents at end of period | $2,026 | $2,178 | $2,026 |
(a) | Working capital includes receivables, inventories, and accounts payable. | ||||||||
See Footnote Table 5 for Reconciliation of Cash Flows from Operating Activities to Free Cash Flow. |
Three Months Ended | |||
September 30, | June 30, | ||
Revenue | 2025 | 2024 | 2025 |
By operating segment: | |||
Completion and Production | $3,223 | $3,299 | $3,171 |
Drilling and Evaluation | 2,377 | 2,398 | 2,339 |
Total revenue | $5,600 | $5,697 | $5,510 |
By geographic region: | |||
North America | $2,364 | $2,386 | $2,259 |
Latin America | 996 | 1,053 | 977 |
Europe/Africa/CIS | 828 | 722 | 820 |
Middle East/Asia | 1,412 | 1,536 | 1,454 |
Total revenue | $5,600 | $5,697 | $5,510 |
Operating Income | |||
By operating segment: | |||
Completion and Production | $514 | $669 | $513 |
Drilling and Evaluation | 348 | 406 | 312 |
Total operations | 862 | 1,075 | 825 |
Corporate and other | (64) | (60) | (66) |
SAP S4 upgrade expense | (50) | (28) | (32) |
Impairments and other charges | (392) | (116) | — |
Total operating income | $356 | $871 | $727 |
See Footnote Table 1 for Reconciliation of Operating Income to Adjusted Operating Income. |
Nine Months Ended | ||
September 30, | ||
Revenue | 2025 | 2024 |
By operating segment: | ||
Completion and Production | $9,514 | $10,073 |
Drilling and Evaluation | 7,013 | 7,261 |
Total revenue | $16,527 | $17,334 |
By geographic region: | ||
North America | $6,859 | $7,413 |
Latin America | 2,869 | 3,258 |
Europe/Africa/CIS | 2,423 | 2,208 |
Middle East/Asia | 4,376 | 4,455 |
Total revenue | $16,527 | $17,334 |
Operating Income | ||
By operating segment: | ||
Completion and Production | $1,558 | $2,080 |
Drilling and Evaluation | 1,012 | 1,207 |
Total operations | 2,570 | 3,287 |
Corporate and other | (196) | (190) |
SAP S4 upgrade expense | (112) | (91) |
Impairments and other charges | (748) | (116) |
Total operating income | $1,514 | $2,890 |
See Footnote Table 2 for Reconciliation of Operating Income to Adjusted Operating Income. |
Three Months Ended | ||||
September 30, | June 30, | |||
2025 | 2024 | 2025 | ||
Operating income | $356 | $871 | $727 | |
Impairments and other charges: | ||||
Severance costs | 169 | 63 | — | |
Fixed and Other assets write-offs | 115 | — | — | |
Impairment of assets held for sale | 96 | 49 | — | |
Cybersecurity incident | (10) | 35 | — | |
Gain on investment | (6) | (43) | — | |
Other | 28 | 12 | — | |
Total impairments and other charges (a) | 392 | 116 | — | |
Adjusted operating income (b) (c) | $748 | $987 | $727 |
(a) | During the three months ended September 30, 2025, Halliburton recognized a pre-tax charge of $392 million as a result of severance costs, fixed and other assets write-offs, an impairment of assets held for sale, and other items. During the three months ended September 30, 2024, Halliburton recognized a pre-tax charge of $116 million as a result of severance costs, an impairment of assets held for sale, expenses related to a cybersecurity incident, a gain on a fair value adjustment of an equity investment, and other items. | |||||
(b) | Adjusted operating income is a non-GAAP financial measure which is calculated as: “Operating income” plus “Total impairments and other charges” for the respective periods. Management believes that operating income adjusted for impairments and other charges is useful to investors to assess and understand operating performance, especially when comparing those results with previous and subsequent periods or forecasting performance for future periods, primarily because management views the excluded items to be outside of the company's normal operating results. Management analyzes operating income without the impact of these items as an indicator of performance, to identify underlying trends in the business, and to establish operational goals. The adjustments remove the effect of these items. | |||||
(c) | We calculate operating margin by dividing operating income by revenue. We calculate adjusted operating margin, a non- GAAP financial measure, by dividing adjusted operating income by revenue. Management believes adjusted operating margin is useful to investors to assess and understand operating performance. |
Nine Months Ended | |||
September 30, | |||
2025 | 2024 | ||
Operating income | $1,514 | $2,890 | |
Impairments and other charges: | |||
Severance costs | 276 | 63 | |
Impairment of assets held for sale | 200 | 49 | |
Fixed and Other assets write-offs | 115 | — | |
Impairment of real estate facilities | 53 | — | |
Cybersecurity incident | (10) | 35 | |
Gain on investment | (6) | (43) | |
Other | 120 | 12 | |
Total impairments and other charges (a) | 748 | 116 | |
Adjusted operating income (b) (c) | $2,262 | $3,006 |
(a) | During the nine months ended September 30, 2025, Halliburton recognized a pre-tax charge of $748 million as a result of severance costs, an impairment of assets held for sale, fixed and other assets write-offs, an impairment on real estate facilities, and other items, primarily related to legacy environmental remediation cost estimate increases. During the nine months ended September 30, 2024, Halliburton recognized a pre-tax charge of $116 million as a result of severance costs, an impairment of assets held for sale, expenses related to a cybersecurity incident, a gain on a fair value adjustment of an equity investment, and other items. | |||
(b) | Adjusted operating income is a non-GAAP financial measure which is calculated as: “Operating income” plus “Total impairments and other charges” for the respective periods. Management believes that operating income adjusted for impairments and other charges is useful to investors to assess and understand operating performance, especially when comparing those results with previous and subsequent periods or forecasting performance for future periods, primarily because management views the excluded items to be outside of the company's normal operating results. Management analyzes operating income without the impact of these items as an indicator of performance, to identify underlying trends in the business, and to establish operational goals. The adjustments remove the effect of these items. | |||
(c) | We calculate operating margin by dividing operating income by revenue. We calculate adjusted operating margin, a non-GAAP financial measure, by dividing adjusted operating income by revenue. Management believes adjusted operating margin is useful to investors to assess and understand operating performance. |
Three Months Ended | ||||
September 30, | June 30, | |||
2025 | 2024 | 2025 | ||
Net income attributable to company | $18 | $571 | $472 | |
Adjustments: | ||||
Impairments and other charges (a) | 392 | 116 | — | |
Other, net (b) | 23 | — | — | |
Total adjustments, before taxes | 415 | 116 | — | |
Tax valuation allowance (c) | 125 | (41) | — | |
Tax adjustment (c) | (62) | (5) | — | |
Total adjustments, net of taxes (d) | 478 | 70 | — | |
Adjusted net income attributable to company (d) | $496 | $641 | $472 | |
Diluted weighted average common shares outstanding | 850 | 881 | 857 | |
Net income per diluted share (e) | $0.02 | $0.65 | $0.55 | |
Adjusted net income per diluted share (e) | $0.58 | $0.73 | $0.55 |
(a) | See Footnote Table 1 for details of the impairments and other charges recorded during the three months ended September 30, 2025 and September 30, 2024. | |||||
(b) | During the three months ended September 30, 2025, Halliburton incurred a charge of $23 million due to the impairment of an investment in Argentina. | |||||
(c) | The adjustments in the table above include a $125 million tax expense associated with a valuation allowance recorded against our deferred tax assets, which resulted from the impact on the realizability of our United States foreign tax credits due to the “One Big Beautiful Bill Act” (OBBBA), as well as the tax effect on impairments and other charges and the impairment of an investment in Argentina recorded during the three months ended September 30, 2025. During the three months ended September 30, 2024, the adjustments include a $41 million tax benefit associated with a partial release of a valuation allowance on deferred tax assets based on market conditions, as well as the tax effect on impairments and other charges. | |||||
(d) | Adjusted net income attributable to company is a non-GAAP financial measure which is calculated as: “Net income attributable to company” plus “Total adjustments, net of taxes” for the respective periods. Management believes net income adjusted for impairments and other charges and Argentina investment impairment, along with the tax adjustment, is useful to investors to assess and understand operating performance, especially when comparing those results with previous and subsequent periods or forecasting performance for future periods, primarily because management views the excluded items to be outside of the company's normal operating results. Management analyzes net income without the impact of these items as an indicator of performance to identify underlying trends in the business and to establish operational goals. Total adjustments remove the effect of these items. | |||||
(e) | Net income per diluted share is calculated as: “Net income attributable to company” divided by “Diluted weighted average common shares outstanding.” Adjusted net income per diluted share is a non-GAAP financial measure which is calculated as: “Adjusted net income attributable to company” divided by “Diluted weighted average common shares outstanding.” Management believes adjusted net income per diluted share is useful to investors to assess and understand operating performance. |
Nine Months Ended | |||
September 30, | |||
2025 | 2024 | ||
Net income attributable to company | $694 | $1,886 | |
Adjustments: | |||
Impairments and other charges (a) | 748 | 116 | |
Other, net (b) | 23 | 82 | |
Total adjustments, before taxes | 771 | 198 | |
Tax valuation allowance (c) | 125 | (41) | |
Tax adjustment (c) | (105) | (14) | |
Total adjustments, net of taxes (d) | 791 | 143 | |
Adjusted net income attributable to company (d) | $1,485 | $2,029 | |
Diluted weighted average common shares outstanding | 858 | 886 | |
Net income per diluted share (e) | $0.81 | $2.13 | |
Adjusted net income per diluted share (e) | $1.73 | $2.29 |
(a) | See Footnote Table 2 for details of the impairments and other charges recorded during the nine months ended September 30, 2025 and September 30, 2024. | |||
(b) | During the nine months ended September 30, 2025, Halliburton incurred a charge of $23 million due to the impairment of an investment in Argentina. During the nine months ended September 30, 2024, Halliburton incurred a charge of $82 million in March 2024, primarily due to the impairment of an investment in Argentina and currency devaluation in Egypt. | |||
(c) | The adjustments in the table above include a $125 million tax expense associated with a valuation allowance recorded against our deferred tax assets, which resulted from the impact on the realizability of our United States foreign tax credits due to the OBBBA, as well as the tax effect on impairments and other charges and the impairment of an investment in Argentina, recorded during the nine months ended September 30, 2025. During the nine months ended September 30, 2024, the adjustments include a $41 million tax benefit associated with a partial release of a valuation allowance on deferred tax assets based on market conditions, the tax effects on impairments and other charges, the impairment of an investment in Argentina, and Egypt currency impact. | |||
(d) | Adjusted net income attributable to company is a non-GAAP financial measure which is calculated as: “Net income attributable to company” plus “Total adjustments, net of taxes” for the respective periods. Management believes net income adjusted for the impairments and other charges, Egypt currency impact, and Argentina investment impairments, along with the tax adjustment, is useful to investors to assess and understand operating performance, especially when comparing those results with previous and subsequent periods or forecasting performance for future periods, primarily because management views the excluded items to be outside of the company's normal operating results. Management analyzes net income without the impact of these items as an indicator of performance to identify underlying trends in the business and to establish operational goals. Total adjustments remove the effect of these items. | |||
(e) | Net income per diluted share is calculated as: “Net income attributable to company” divided by “Diluted weighted average common shares outstanding.” Adjusted net income per diluted share is a non-GAAP financial measure which is calculated as: “Adjusted net income attributable to company” divided by “Diluted weighted average common shares outstanding.” Management believes adjusted net income per diluted share is useful to investors to assess and understand operating performance. |
Nine Months Ended | Three Months Ended | ||
September 30, | September 30, | ||
2025 | 2024 | 2025 | |
Total cash flows provided by operating activities | $1,761 | $2,409 | $488 |
Capital expenditures | (917) | (1,016) | (261) |
Proceeds from sales of property, plant, and equipment | 138 | 149 | 49 |
Free cash flow (a) | $982 | $1,542 | $276 |
(a) | Free Cash Flow is a non-GAAP financial measure which is calculated as “Total cash flows provided by operating activities” less “Capital expenditures” plus “Proceeds from sales of property, plant, and equipment.” Management believes that Free Cash Flow is a key measure to assess liquidity of the business and is consistent with the disclosures of Halliburton's direct, large-cap competitors. |